A phase II study of niraparib plus bevacizumab maintenance following frontline platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: Final analysis from the OVARIO study
作者
Melissa M. Hardesty,Thomas C. Krivak,Gail Lynn Shaw Wright,Erika Hamilton,Evelyn Fleming,J Belotte,Shelby Gorman,Natalie Compton,Aine Clements,Heidi J. Gray,Gottfried E. Konecny,Richard G. Moore,Debra L. Richardson